9-Methoxycamptothecin (MCPT) was found to have antitumour activities through topoisomerase inhibition. However, the type of cell death induced in the tumour cells treated with MCPT was not elucidated. In this study, MCPT and camptothecin were isolated from Nothapodytes foetida distributed in Hubei Province, China and identifi ed by NMR spectroscopy. MCPT was tested by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay using camptothecin as reference. Annexin V-FITC/propidium iodide double staining and real-time PCR were also performed. The IC 50 value was (0.385  0.08) µM. The apoptosis rates increased from 9.5% to 17.27%, 30.14%, and 66.46% with an increase in MCPT concentrations from 0, 0.19, 0.38, to 0.95 µM, respectively. The ratio of Bax/Bcl-2 also increased from 1 to 1.61, 2.43, and 4.57, respectively. Bax and Bcl-2 are crucial to the mitochondria pathway. The results indicate that the mitochondria pathway may be involed in MCPT-induced murine sarcoma S180 apoptosis.
Introduction
Apoptosis, also referred to as cell-programmed suicide, is a form of cell death. An abnormality in apoptosis causes neurodegeneration and malignancy, which may lead to uncontrolled cell growth. Therefore, the induction of cancer cell apoptosis is a very useful method of cancer therapy. Apoptosis is a complex endogenous gene-controlled event (Yang et al., 2009) , and the Bcl-2 family proteins play an important role in the intrinsic apoptotic pathway (mitochondria pathway). Bcl-2 and Bax proteins, which are members of the Bcl-2 protein family, are crucial to this pathway (Youle and Strasser, 2008) . The Bcl-2 protein is the fi rst proto-oncogene and is overexpressed in malignancy (Buolamwini, 1999) . Bcl-2 reportedly blocks the release of cytochrome c from the mitochondria (Yang et al., 1997) , arresting the mitochondria pathway. In contrary, The Bax protein shows pro-apoptotic effect in the mitochondria pathway. Under homeostatic conditions, Bcl-2 maintains mitochondrial integrity by preventing Bax from causing mitochondrial damage (Duprez et al., 2009) . Therefore, the effects of Bax and Bcl-2 in the mitochondria pathway should be considered simultaneously.
Nothapodytes foetida syn. Mappia foetida is a species of the family Icacinaceae, which is mainly distributed in India (Govindachari and Viswanathan, 1972) and Taiwan (Wu et al., 1996) . Its phytochemistry has been extensively researched locally because it is a potential source of anticancer drugs. A number of camptothecinoids (CPTs), other alkaloids, and phytochemicals have been reported from this plant (Wu et al., 2008) . 9-Methoxy camptothecin (MCPT) is the main antitumour compound in Nothapodytes foetida (Hsiao et al., 2008) . The NCI database confi rmed that MCPT has a broad range of antitumour activities against various human tumour cell lines in vitro and in vivo (http://dtp.cancer.gov/index. html). MCPT was reported to inhibit topoisomerase I (Pommier et al., 1991) . Generally, potent antitumour coumpounds usually display multiple antitumour mechanisms. Cell death in mammals can be classifi ed into different types, namely, apoptosis, necrosis, and autophagy (Portugal et al., 2009) . MCPT is an effective antitumour compound. However, the specifi c mechanism for inducing cell death in tumour cells treated with MCPT has not been elucidated, trials testing MCPT against murine sarcoma S180 cells have not been performed, and MCPT-induced tumour cell apoptosis has not been reported. In the present study, MCPT and camptothecin (CPT) were isolated from N. foetida and their antitumour activities were tested on murine sarcoma S180 cells. Annexin V-FITC/propidium iodide (PI) double staining assays were employed to detect MCPT-induced murine sarcoma S180 cell apoptosis, and real-time PCR was employed to investigate the expression of Bax and Bcl-2 genes.
9-Methoxycamptothecin from Nothapodytes foetida

Material and Methods
Plant material
The stems of N. foetida were collected from Hubei Province, China in October 2008. A voucher specimen (Yue Dai 001010) was deposited at the Guangxi Institute of Botany, Chinese Academy of Sciences (Guilin, China).
Reagents and instrumentation
RPMI-1640 culture medium and fetal bovine serum (FBS) were purchased from HyClone (Logan, USA). The apoptosis detection kit was purchased from Key Gen Biotech Co. (Nanjing, China). TRIzol reagent was purchased from Invitrogen (Carlsbad, USA). The ReverTra Ace qPCR RT kit was purchased from Toyobo (Osaka, Japan). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) was purchased from Sigma Chemical Co. (St. Louis, MO, USA). Dimethylsulfoxide (DMSO) and methanol were purchased from Merck & Co. Inc. (Darmstadt, Germany). Murine sarcoma S180 ascites cells were obtained from the Cancer Research Institute of Hubei Province ( Wuhan, China). All other chemicals were purchased from a local chemical market (Wuhan, China) .
A Nikon Alphaphot-2 YSZ microscope was used for counting cells (Tokyo, Japan); an enzymelinked immunosorbent assay meter (Tecan Group Ltd., Mannedorf, Switzerland) for the MTT assay; BD FACSCalibur and CellQuest software (Franklin Lakes, USA) for the cell apoptosis assay; an ABI Prism 7000 Sequence Detector System (Norwalk, USA) for real-time PCR; an AV-400 nuclear magnetic resonance (NMR) instrument (Brucker Co., Fällanden, Switzerland) for NMR spectroscopy assay; an Agilent 1100 HPLC (Santa Clara, USA) instrument, an ESI spectrometer (Agilent G2440 MSD-Trap-XCT ion trap mass spectrometer), and an Agilent chromatographic column (XDB-C 18 , 4.6 × 150 mm, 5 µm) for liquid chromatography-mass spectrometry (LC-MS).
Extraction and isolation
N. foetida stems were powdered and extracted with methanol. The extracts were concentrated and further fractionated by liquid-liquid extraction with aqueous hydrochloric acid solution (pH 3 -4) and dichloromethane. The dichloromethane fraction was concentrated and subsequently separated using silica gel eluted with methanol/ dichloromethane (0:100 -20:80) to produce two compounds of over 95% purity. Compound identifi cation was performed by NMR spectroscopy and LC-MS.
Cell culture
The cells were grown in RPMI-1640 medium supplemented with 10% (v/v) FBS, 100 µg/ml streptomycin and 100 U/ml penicillin at 37 °C in a humid atmosphere containing 5% CO 2 .
MTT assay
The cytotoxicity assay was performed using the MTT method (Wang et al., 2006) . The cells were incubated in 96-well plates at a density of 5 · 10 3 cells per well and exposed for 24 h to a series of varying concentrations of MCPT and CPT. Next, 5 µl of MTT (5 mg/ml) were added to each well. The plates were incubated for another 4 h at 37 °C under 5% CO 2 . The murine sarcoma S180 cells were then collected and solubilized for 15 min with 150 µl DMSO. The absorbance at 570 nm was determined using an enzyme mark instrument.
Flow cytometric analysis
The apoptosis-mediated deaths of murine sarcoma S180 cells treated with varying concentrations of MCPT were examined using an Annexin V-FITC/PI apoptosis detection kit (Annexin V-FITC, PI, and binding buffer) according to the manufacturer's instructions. After 24 h of treat-ment with 0, 0.19, 0.38, and 0.95 µM MCPT, the murine sarcoma S180 cells were collected and washed twice in cold phosphate buffered saline (PBS). Then 2 · 10 5 cells were collected, added to 500 µl binding buffer, and stained with 5 µl Annexin V-FITC and 5 µl PI for 10 min at 25 °C in the dark. Finally, fl ow cytometry was used to quantify cell death induced by MCPT. Data acquisition and analysis were performed using BD FACSCalibur and CellQuest software.
Quantitative real-time PCR
Total RNA of murine sarcoma S180 cells treated for 24 h with different concentrations of MCPT were extracted with TRIzol reagent and confi rmed by quantitative real-time PCR with the ReverTra Ace qPCR RT kit, following the manufacturer's protocols. Quantitative real-time PCR was performed on an ABI Prism 7000 Sequence Detector System. The specifi c primer pairs included Bcl-2 (forward, 5'-CAT TGG GAA GTT TCA AAT CAG C-3', and reverse, 5'-CTT TGC ATT CTT GGA CGA GG-3'), Bax (forward, 5'-TTG CTT CAG GGT TTC ATC CA-3', and reverse, 5'-CAG CCT TGA GCA CCA GTT TG-3'), and actin (forward, 5'-GTC CAC CGC AAA TGC TTC TA-3', and reverse, 5'-TGC TGT CAC CTT CAC CGT TC-3'). The PCR mixture was initially pre-heated for 2 min each at 50 and 95 °C before undergoing 40 cycles of amplifi cation. The amplifi cation program consisted of incubation at 95 °C for 15 s, 58 °C for 15 s, 72 °C for 45 s, and 72 °C for 10 min. All determinations were performed in triplicate.
Statistical analysis
All data were expressed as means  SD. Statistical analyses were performed using an unpaired, two-tailed Student t-test. All comparisons were made relative to untreated controls, and significance differences were indicated by *P < 0.01.
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Results and Discussion
Structure elucidation of the compounds
The NMR spectra of compounds 1 and 2 isolated from N. foetida were identifi ed as those of CPT and MCPT (Zhou et al., 2000) . The N. foetida samples from Hubei Province, China are identical to N. foetida found in India (Srinivas and Das, 2003) .
Antitumour activity in vitro
The MTT assay was used to examine the inhibitory effect of MCPT on tumour cells; CPT was used as positive control. Fig. 1 shows that following 24 h of treatment, MCPT effectively decreased the viability of murine sarcoma S180 cells, as shown by an IC 50 value of (0.385  0.08) µM. After the same duration of treatment, CPT showed an IC 50 value of (0.904  0.14) µM. These results indicate that MCPT can signifi cantly inhibit the growth of murine sarcoma S180 cells in a dose-dependent manner and has better antitumour activity than CPT. The antitumour activities of CPT derivatives have attracted substantial attention for years. Extensive studies on the synthesis of CPT analogues and their structure-activity relationships have emerged and suggest that C9-or lipophilic substitution of CPT can increase the antitumour activity (Huang et al., 2007; Van Hattum et al., 2000) . MCPT is a C9-substituted lipophilic derivative of CPT, and its remarkable activity confi rms the structure-activity relationship of CPT.
MCPT-induced apoptosis in murine sarcoma S180 cells
To confi rm the apoptosis induced by MCPT, Annexin V/PI staining was performed. As shown in Fig. 2 , the number of early and middle apoptotic cells increased from 9.5% to 17.27%, 30.14%, and 66.46% after 24 h of treatment with 0, 0.19, 0.38, and 0.95 µM MCPT, respectively. In contrast, the number of early and middle apoptotic cells only increased from 7.17% to 10.9%, 12.84%, and 17.59% after 24 h of treatment with 0, 0.45, 0.91, and 2.7 µM CPT, respectively (data not shown).
The major hallmark of apoptosis is translocation of phosphatidylserine from the inner leafl et of the phospholipid bilayer to the cell surface (Zeng et al., 2009) . The Annexin V/PI staining assay is based on this phenomenon. Flow cytometry data indicate that MCPT induced the translocation of phosphatidylserine from the inner leafl et of the phospholipid bilayer to the cell surface. These results indicate that MCPT induced apopto sis in murine sarcoma S180 cells. The apoptosis rate induced by MCPT was by 66.46% higher than that induced by either CPT or its derivatives (Ju et al., 2007; Togano et al., 2009; Wang et al., 2008) . Similar to CPT and its derivatives, MCPT is a topoisomerase I inhibitor (Pommier et al., 1991; Lauria et al., 2007) , but yields better apoptosis rates. Therefore, MCPT may be involved in other mechanisms aside from topoisomerase I inhibition.
MCPT-induced Bax protein level increase in murine sarcoma S180 cells
Quantitative real-time PCR was performed 24 h after the murine sarcoma S180 cells were treated with MCPT. The results show that the RNA levels of Bcl-2 in the treatment groups were lower than those in the control groups. The RNA levels of Bax increased from 1 to 1.13, 1.82, and 3.79 after treatment with 0, 0.19, 0.38, and 0.95 µM MCPT (Fig. 3) , resulting in dose-dependent Bax/ Bcl-2 ratios of 1, 1.61, 2.43, and 4.57, respectively.
Apoptosis is a form of cell death that involves the mitochondria pathway and extracellular pathways. The mitochondria pathway is activated by the Bcl-2 family of proteins, which includes antiapoptotic genes, such as Bcl-2, and pro-apoptotic genes, such as Bax (Duprez et al., 2009 ). There is evidence that an increase in the Bax/Bcl-2 ratio results in activation of apoptosis (Wiebe et al., 2010) . The results suggest that the genes Bax and Bcl-2 activate apoptosis induced by MCPT on murine sarcoma S180 cells. They also indicate that the mitochondria pathway is involved in apopto sis.
The CPT derivatives irinotecan and SN-38 have been applied clinically as topoisomerase inhibitors. Irinotecan and SN-38 are usually combined with other drugs to obtain desired levels of antitumour activity (Miettinen and Ylikomi, 2009) . These synergistic drugs function by increasing the Bax/Bcl-2 ratio, which in turn triggers tumour cell apoptosis (Chen et al., 2003) . MCPT, a topoisomerase inhibitor, does not require combination with other drugs to increase the ratio of Bax and Bcl-2 successfully.
Conclusion
MCPT isolated from N. foetida showed good antitumour activity and induced a high apoptotic rate in murine sarcoma S180 cells. MCPT also increased the Bax/Bcl-2 ratio in these cells. This mechanism is also exhibited by other topoisomerase inhibitors in combination with other antitumour agents. The mechanisms of Bax-and Bcl-2-mediated apoptosis induced by MCPT, however, are not yet fully understood, and further studies are necessary. These fi ndings indicate that the mitochondria pathway is involed in MCPTinduced murine sarcoma S180 apoptosis.
